GlaxoSmithKline CR`s Total Cash From Financing reached -38.0 CZK mil in 2017. This is 69.5 % less than in the previous year.
Buy Total Cash From Financing data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
Company | Unit | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
Amgen Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | 0 | 0 | -60.0 | -0.028 | -60.0 | |||||||
Bayer Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
GlaxoSmithKline Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |||||||
Merck Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||
Novartis Czech Republic | CZK mil | 0 | 0 | 0 | 0 | 0 | |||||||||||||
Pfizer Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ||||||||
Roche Czech Republic | CZK mil | ... | ... | ... | 0 | 0 | 0 | 56.2 | 118 | ... | |||||||||
Sanofi-Aventis Czech Republic | CZK mil | ... | ... | ... | ... | -99.4 | 245 | 0 | 0 | -67.1 | |||||||||
Servier Czech Republic | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | -25.0 | 0 | 0 | 0 | ||
Walmark | CZK mil | ... | ... | ... | -126 | -24.0 | 136 | 132 | 641 |